Back
Moderna, Inc. Vs. Merck & Co., Inc. Industry Stock Comparison
Sell
30
MRNA
Moderna, Inc.
Last Price:
$30.40
Seasonality Move:
2.78%
Buy
68
MRK
Merck & Co., Inc.
Last Price:
$106.09
Seasonality Move:
0.72%
Sell
30
Moderna, Inc. (MRNA)
is a Sell
Is Moderna, Inc. a Buy, Sell or Hold?
-
The current Moderna, Inc. [MRNA] share price is $31.15. The Score for MRNA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
MRNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Merck & Co., Inc. (MRK)
is a Buy
Is Merck & Co., Inc. a Buy, Sell or Hold?
-
The current Merck & Co., Inc. [MRK] share price is $106.62. The Score for MRK is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
MRK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MRNA Stock Price Chart
What is Moderna, Inc.'s stock price today?
-
The Moderna, Inc. share price today is $31.15The current trend is moderately bullish and MRNA is experiencing selling pressure, which indicates risk of future bearish movement.
MRK Stock Price Chart
What is Merck & Co., Inc.'s stock price today?
-
The Merck & Co., Inc. share price today is $106.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRK is experiencing slight selling pressure.
MRNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.74 | Buy |
| Relative Strength Index (14 RSI): | 58.12 | Buy |
| Chaikin Money Flow: | 4202787 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
MRK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.86 | Buy |
| Relative Strength Index (14 RSI): | 70.2 | Buy |
| Chaikin Money Flow: | -5379691 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
MRNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.19 | Sell |
| 20-day SMA: | 29.41 | Buy |
| 50-day SMA: | 26.99 | Buy |
| 200-day SMA: | 27.45 | Buy |
| 8-day EMA: | 31.61 | Sell |
| 20-day EMA: | 29.96 | Buy |
| 50-day EMA: | 28.03 | Buy |
| 200-day EMA: | 31.84 | Sell |
MRK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 103.82 | Buy |
| 20-day SMA: | 101.38 | Buy |
| 50-day SMA: | 95.06 | Buy |
| 200-day SMA: | 85.48 | Buy |
| 8-day EMA: | 104.4 | Buy |
| 20-day EMA: | 101.62 | Buy |
| 50-day EMA: | 96.56 | Buy |
| 200-day EMA: | 90.81 | Buy |
Moderna, Inc. Earnings Growth & MRNA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.15 per share, and an increase next year of $2.27 per share.
Merck & Co., Inc. Earnings Growth & MRK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.00 per share.
Moderna, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Merck & Co., Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||